The estimated Net Worth of Patrick Joseph Gallagher is at least $260 Thousand dollars as of 24 August 2022. Mr. Gallagher owns over 17,000 units of Biosig Technologies Inc stock worth over $44,800 and over the last 9 years he sold BSGM stock worth over $0. In addition, he makes $214,806 as Independent Director at Biosig Technologies Inc.
Patrick has made over 3 trades of the Biosig Technologies Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 17,000 units of BSGM stock worth $19,720 on 24 August 2022.
The largest trade he's ever made was buying 20,000 units of Biosig Technologies Inc stock on 9 March 2018 worth over $28,000. On average, Patrick trades about 4,385 units every 178 days since 2016. As of 24 August 2022 he still owns at least 100,000 units of Biosig Technologies Inc stock.
You can see the complete history of Mr. Gallagher stock trades at the bottom of the page.
Patrick J. Gallagher serves as Independent Director of the Company. Mr. Gallagher has served as our director since July 2014. Mr. Gallagher, MBA, CFA, is an accomplished capital markets executive, advisor, and investor with a distinguished record of success in both the public and private markets. He has nearly 20 years of experience on Wall Street and extensive expertise in alternative investments, capital markets, and marketing. Since September 2014, Mr. Gallagher has served as senior managing director and head of healthcare sales at Laidlaw & Co. (UK) Ltd. Mr. Gallagher serves as a strategic consultant for Athenex, Inc., a biopharmaceutical firm focused on next-generation therapies in oncology and immunology and was the vice president of business development and investor relations from September 2012 to October 2013. He also sits on the board of directors of Cingulate Therapeutics since July 2013, a clinical stage biopharmaceutical company focused on innovative new products for ADHD, as well as Evermore Global Advisors, a global money manager since May 2015. In November 2010, he was appointed by broker Concept Capital, a division of Sanders Morris Harris, as a managing director and the head of institutional sales. In 2001, Mr. Gallagher co-founded BDR Research Group, LLC, an independent sell-side research firm specializing in healthcare investing, financing and operations, and served as its chief executive officer until November 2010. Prior to 2001, he held various sales positions at investment and research firms Kidder Peabody, PaineWebber and New Vernon Associates. Mr. Gallagher is a CFA charter holder, received his MBA from Pennsylvania State University and holds a B.S. degree in finance from the University of Vermont.
As the Independent Director of Biosig Technologies Inc, the total compensation of Patrick Gallagher at Biosig Technologies Inc is $214,806. There are 7 executives at Biosig Technologies Inc getting paid more, with Kenneth Londoner having the highest compensation of $5,034,850.
Patrick Gallagher is 55, he's been the Independent Director of Biosig Technologies Inc since 2014. There are 9 older and 3 younger executives at Biosig Technologies Inc. The oldest executive at Biosig Technologies Inc is Dr. Budimir S. Drakulic Ph.D., 71, who is the Chief Scientist.
Patrick's mailing address filed with the SEC is C/O BIOSIG TECHNOLOGIES, INC., 55 GREENS FARMS ROAD, WESTPORT, CT, 06880.
Over the last 9 years, insiders at Biosig Technologies Inc have traded over $1,778,587 worth of Biosig Technologies Inc stock and bought 1,345,515 units worth $2,296,289 . The most active insiders traders include Kenneth L Londoner, Asher Holzer, and Jerome B Zeldis. On average, Biosig Technologies Inc executives and independent directors trade stock every 24 days with the average trade being worth of $11,433. The most recent stock trade was executed by Kenneth L Londoner on 13 June 2023, trading 15,600 units of BSGM stock currently worth $19,344.
biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.
Biosig Technologies Inc executives and other stock owners filed with the SEC include: